Science Corporation says its retinal implant restored central vision in patients who were legally blind in a clinical trial.

Precision Neuroscience Corp., a brain implant rival to Elon Musk’s Neuralink Corp., has raised $93 million of a planned $100 ...

Synchron CEO Tom Oxley hopes Donald Trump will revive a proposed a new rule – which Joe Biden pulled back – to get ...

Science Corporation's retinal implant allowed some people who lost their central vision to read, play cards, and recognize faces.

Neuralink’s device went into its first human patient as part of a trial earlier this year. And a team at the University of California, Davis, implanted an ALS patient with a device that allowed ...

In September, Neuralink received a "breakthrough device ... It's likely years away from completing a clinical trial, however. More substantively, Science Corp's latest clinical trial, the findings ...

S cience Corporation, a rival to Elon Musk’s Neuralink in the development of brain-computer interface (BCI) technology, has just unveiled promising early clinical trial results for an eye implant that ...

Neuralink has claimed in a tweet that it has finally received approval from the FDA to start a first-in-human clinical trial of its brain implant chip – but hasn’t indicated when it may start.

Billionaire entrepreneur Elon Musk's brain-chip startup Neuralink said on Tuesday it has received approval from an independent review board to begin recruitment for the first human trial of its ...

A team of researchers designed a eye implant that has enabled legally blind patients to read again, sparking new competition with Neuralink.